Company Description
Nu-Med Plus (OTC Link: NUMD) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $1.3M.
NUMD has declined 63.2% over the past year. Shares last traded at $0.0184.
For FY2025, Nu-Med Plus and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for NUMD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nu-Med Plus (NUMD) stock last closed at $0.0184. Over the past 12 months, the stock has lost 63.2%. At a market capitalization of $1.3M, NUMD is classified as a micro-cap stock with approximately 83.5M shares outstanding.
Latest News
Nu-Med Plus has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all NUMD news →
SEC Filings
Nu-Med Plus has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on July 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NUMD SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Nu-Med Plus (NUMD) currently stands at 36.4 thousand shares, down 63.4% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Nu-Med Plus (NUMD) currently stands at 1.0 days, down 76.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
NUMD Company Profile & Sector Positioning
Nu-Med Plus (NUMD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.